Autoimmun betegségek kezelése autológ haemopoeticus ossejtekkel

Translated title of the contribution: Autoimmune diseases treated by autologous haemopoietic stem cells

Research output: Contribution to journalArticle


Autoimmune diseases are of multifactorial origin. Due to the disturbed immune tolerance, autoreactive T and B cells target self antigens, which lead to permanent organ damages. Despite of the recently introduced therapeutic protocols, the disease has a chronic course, in many cases with lethal outcome. The efficacy of stem cell therapy has been observed in animal models of autoimmune diseases and in autoimmune diseases associated with haematological disorders. Although this approach has been applied for more than 30 years, its widespread use has been delayed by the serious side effects caused by the conditioning treatments based on oncological protocols. The evaluation of the data of patients who had undergone autologous stem cell therapy revealed that the use of protocols for conditioning treatments that mostly cause lymphoablation, and also, if the procedures are carried out in specialized centres significantly reduce mortality, while the therapeutic efficacy remains optimal. Indications for autologous CD34+ stem cell therapy in patients with autoimmune diseases are internationally established and accepted. New, multicentric investigations have been launched in order to compare the efficacy of various protocols.

Translated title of the contributionAutoimmune diseases treated by autologous haemopoietic stem cells
Original languageHungarian
Pages (from-to)853-858
Number of pages6
JournalLege Artis Medicinae
Issue number12
Publication statusPublished - Dec 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Autoimmune diseases treated by autologous haemopoietic stem cells'. Together they form a unique fingerprint.

  • Cite this